Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...

Mechanism of Angiogenesis

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Characterizing the effects of MSC lipid remodeling via sphingomyelinase licensing through morphological, metabolic, and secretome profiling.

Cytotherapy·2026

Same author

Investigating FTY720-NF immunomodulation of key lipid, gene, and protein mediators to enhance oral tissue regeneration.

Biomaterials advances·2026

Same author

PAVR: High-Resolution Cellular Imaging via a Physics-Aware Volumetric Reconstruction Framework.

bioRxiv : the preprint server for biology·2026

Same author

Exogenous sphingomyelinase mediates MSC-derived EV biogenesis and enhances potency via repackaging of molecular cargo.

iScience·2026

Same author

Radiomic Features Extracted from Magnetic Resonance Imaging to Identify Arteriopathy in a Humanized Mouse Model of Sickle Cell Anemia and Sickle Cell Trait.

Annals of biomedical engineering·2026

Same author

Resolving versus non-resolving sphingolipid dynamics during macrophage activation: a time-resolved metabolic analysis.

Journal of lipid research·2025

Search research articles

Related Experiment Video

Updated: Jun 24, 2026

Implantation of Tissue-Engineered Vascular Graft in Mouse Carotid Artery via Cuff Technique

Implantation of Tissue-Engineered Vascular Graft in Mouse Carotid Artery via Cuff Technique

Published on: May 2, 2025

Engineering vascularized tissues using natural and synthetic small molecules.

Lauren S Sefcik¹, Caren E Petrie Aronin, Edward A Botchwey

¹Department of Biomedical Engineering; and Department of Orthopaedic Surgery; University of Virginia; Charlottesville, Virginia USA; Center for Immunity, Inflammation and Regenerative Medicine (CIIR); University of Virginia; Charlottesville, Virginia USA.

|April 2, 2009

Summary

Exploring novel small molecules for therapeutic neovascularization is crucial. This review discusses transcriptional activators, receptor modulators, and natural/synthetic compounds to improve vascular growth beyond current protein-based therapies.

Keywords:

angiogenesis arteriogenesis drug discovery ischemic tissue disease neovascularization small molecule tissue engineering vascular development

More Related Videos

Tissue Engineering by Intrinsic Vascularization in an In Vivo Tissue Engineering Chamber

Tissue Engineering by Intrinsic Vascularization in an In Vivo Tissue Engineering Chamber

Published on: May 30, 2016

Micropatterning and Assembly of 3D Microvessels

Micropatterning and Assembly of 3D Microvessels

Published on: September 9, 2016

Related Experiment Videos

Last Updated: Jun 24, 2026

Implantation of Tissue-Engineered Vascular Graft in Mouse Carotid Artery via Cuff Technique

Implantation of Tissue-Engineered Vascular Graft in Mouse Carotid Artery via Cuff Technique

Published on: May 2, 2025

Tissue Engineering by Intrinsic Vascularization in an In Vivo Tissue Engineering Chamber

Tissue Engineering by Intrinsic Vascularization in an In Vivo Tissue Engineering Chamber

Published on: May 30, 2016

Micropatterning and Assembly of 3D Microvessels

Micropatterning and Assembly of 3D Microvessels

Published on: September 9, 2016

Area of Science:

Vascular biology and regenerative medicine

Background:

Vascular growth and remodeling require precise signaling for functional networks.
Current protein-based therapies (VEGF, FGF) for neovascularization show disappointing clinical trial results.
Safer, more effective therapeutic strategies are needed.

Purpose of the Study:

To review novel small molecule approaches for inducing and enhancing therapeutic neovascularization.
To explore drug discovery pathways beyond established protein factors.

Main Methods:

Review of existing and novel small molecule classes.
Discussion of transcriptional activators.
Analysis of receptor selective agonists and antagonists.
Examination of natural product-derived and synthetic small molecules.

Main Results:

Identified four classes of small molecules with potential for therapeutic neovascularization.
Highlighted the need to explore diverse molecular agents.
Emphasized small molecules as a promising alternative to protein-based therapies.

Conclusions:

Small molecules offer a promising avenue for novel drug discovery in therapeutic neovascularization.
Further research into these molecular classes could lead to improved treatments for vascular diseases.